Edding Genor Group Holdings Ltd
06998
Company Profile
Business description
Edding Genor Group Holdings Ltd is a biopharmaceutical company with the vision of China for Global. Its major therapeutic areas include oncology, autoimmune, cardiovascular, respiratory and anti-infectives. Its drugs includes Vascepa, Mulpleta, Jingzhuda, and Rujianing.
Contact
248 Queen’s Road East
40th Floor, Dah Sing Financial Centre
Wanchai
Hong Kong
HKGSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Undervalued Aussie e-commerce winner
Shares attractive due to near term profit margin increase and structural growth.
stocks
Our view on oil prices after Maduro is deposed
We’ve revisited our oil price assumptions after the news from Venezuela.
stocks
Nvidia: Full steam ahead with an impressive array of announcements at CES 2026
Our view of Nvidia at the current share price.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,037.90 | 1.60 | -0.02% |
| CAC 40 | 8,237.43 | 25.93 | 0.32% |
| DAX 40 | 24,892.20 | 23.51 | 0.09% |
| Dow JONES (US) | 49,462.08 | 484.90 | 0.99% |
| FTSE 100 | 10,122.73 | 118.16 | 1.18% |
| HKSE | 26,448.25 | 262.20 | -0.98% |
| NASDAQ | 23,547.17 | 151.35 | 0.65% |
| Nikkei 225 | 52,257.11 | 260.97 | -0.50% |
| NZX 50 Index | 13,724.48 | 60.90 | 0.45% |
| S&P 500 | 6,944.82 | 42.77 | 0.62% |
| S&P/ASX 200 | 8,719.50 | 4.00 | -0.05% |
| SSE Composite Index | 4,085.88 | 2.21 | 0.05% |